Keywords: glaxosmithkline, 4th-qtr, eps, rises, world, second-largest, drugmaker
GlaxoSmithKline 4th-qtr EPS rises 15%
Article | 14 February 2005
GlaxoSmithKline, the world's second-largest drugmaker, reported a 17% rise in fourth-quarter 2004 pretax profit at L1.39 billion ($2.53 billion) at constant exchange rates ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
